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Background: We may improve our understanding of the role of common versus unique risk factors in attention-
deficit/hyperactivity disorder (ADHD) by examining ADHD-related cognitive deficits in single- (SPX), and 
multi-incidence (MPX) families. Given that individuals from MPX families are likely to share genetic 
vulnerability for the disorder, whereas SPX ADHD may be the result of sporadic (non-)genetic causes unique to 
the patient, we hypothesized that cognitive impairments may be different in SPX and MPX ADHD as indicated 
by (a) the presence of cognitive deficits in MPX, but not SPX unaffected siblings and (b) dissimilar cognitive 
profiles in SPX and MPX ADHD patients. 
Methods: Tasks measuring total IQ, verbal attention, executive functioning, motor functioning, and time 
estimation were administered to 31 SPX/264 MPX ADHD probands, 47 SPX/123 MPX unaffected siblings, and 
263 controls, aged 6-19 years.  
Results: SPX unaffected siblings were unimpaired compared to controls, except for verbal working memory, 
whereas MPX unaffected siblings showed impairments on most cognitive domains. The cognitive profiles of 
SPX and MPX probands were highly similar, except that verbal attention, response inhibition and motor control 
deficits were more pronounced in MPX probands, and -compared to their unaffected siblings- impairments in IQ, 
visual working memory and timing abilities were more pronounced in SPX cases. 
Conclusions: Our results support the hypothesis that a partly different cognitive architecture may underlie SPX 
and MPX forms of ADHD, which becomes evident when contrasting cognitive performances within families. 
Cognitive factors underlying MPX forms of ADHD are familial, whereas non-familial in SPX ADHD. SPX-
MPX stratification may be a step forward in unravelling diverse causal pathways.  
 
Keywords: Attention-Deficit/Hyperactivity Disorder (ADHD); simplex-multiplex stratification; family; 
unaffected relative; endophenotype 
 
Abbreviations: 
ADHD = attention-deficit/hyperactivity disorder 
SPX = simplex 
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ASD = autism spectrum disorders 
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SSRT = stop signal reaction time 




Attention-deficit/hyperactivity disorder (ADHD) is a severely impairing neurodevelopmental disorder, 
characterized by symptoms of hyperactivity, impulsivity and/or inattention (Diagnostic and Statistical Manual of 
Mental Disorders; DSM-5) (APA, 2013). ADHD is a highly heritable disorder, with heritability estimates 
ranging to 76% (Faraone et al., 2005, Thapar et al., 2013). Common to ADHD is the large within-disorder 
heterogeneity, in symptom presentation, developmental course and underlying etiological mechanisms 
(Wahlstedt et al., 2009). The prevailing etiological model suggests that ADHD is caused by small disease-
increasing effects of multiple common genetic and environmental risk factors (Franke et al., 2009, Thapar et al., 
2013). However several recent studies report that rare genetic mutations or non-shared environmental factors 
(such as low birth weight and medical conditions) with a large effect may relate to ADHD aetiology as well 
(Williams et al., 2010, Ben Amor et al., 2005). This suggests that while in many cases multifactorial factors, 
possibly shared with (unaffected) relatives, might underlie ADHD, factors uniquely present in affected 
individuals, such as de novo mutations, might underlie the disorder in at least some cases.  
More insight into the role of shared versus unique genetic factors for ADHD might be obtained by 
examining the presence of ADHD-related cognitive deficits in unaffected siblings of ADHD probands in the 
search for cognitive endophenotypes of ADHD. Endophenotypes are defined as heritable vulnerability traits that 
heighten the risk for developing a disorder (Gottesman and Gould, 2003). Endophenotypes offer a simplified 
approach to dissect complex traits by reducing heterogeneity and as such may boost the power for genetic 
analyses, as well as shed light on the functional outcomes of genes (Gottesman and Gould, 2003). Cognitive 
deficits that are present in unaffected siblings and thus shared between affected and unaffected relatives are 
assumed to provide an index of the multifactorial liability to ADHD (Waldman, 2005). Conversely, cognitive 
deficits that are not shared between affected and unaffected siblings may have a unique effect on the 
development of the disorder. This affected-unaffected siblings design has been frequently applied in ADHD 
research and has led to many studies documenting an increased incidence of behavioral symptoms, comorbid 
symptomatology, and ADHD-related cognitive deficits in unaffected family members of ADHD probands (for 
an extensive review see Rommelse et al., 2011).  
We may improve our understanding of the role of common versus unique genetic risk factors in ADHD 
by examining ADHD related cognitive deficits in single-, and multi-incidence ADHD families. We hypothesized 
that ADHD-related cognitive deficits are only present in multi-incidence (here referred to as multiplex; MPX), 
but not single-incidence (here referred to as simplex: SPX) ADHD families. SPX families are defined as nuclear 
families with only one affected individual and at least one unaffected male sibling. MPX families consist of at 
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least two (or more) affected individuals in the family (Sullivan et al., 2012). The assumption is that individuals 
from SPX families are more likely than individuals from MPX families to develop ADHD as a result of sporadic 
genetic and/or non-genetic causes strictly unique to the patient. Then unaffected relatives in SPX families would 
show less or even no behavioral or cognitive deficits compared to controls and would deviate more from the 
cognitive profile of their affected brother or sister. In contrast, unaffected relatives in MPX families would show 
cognitive deficits, compared to controls, and about as similar as the probands. In other words, the within-family 
contrast between probands and unaffected siblings regarding cognitive or behavioral aspects of the disorder is 
larger in SPX compared to MPX families. Unaffected siblings can be viewed as an ideal reference group, 
indexing the ‘full potential’ of children with ADHD had they not developed the disorder (while correcting for 
shared environmental influences). Higher within-family contrasts might thus be indicative of more severely 
impaired cognitive abilities in the affected children from those families. This model of different etiologies in 
SPX and MPX families has been developed and confirmed in research in Autism Spectrum Disorders (ASD) 
(Gerdts et al., 2013, Sebat et al., 2007). For example, a more than threefold rate of de novo mutations were 
identified in ASD SPX families (~7-10%), compared to ASD MPX families (~2-3%) or control families (~1%) 
(Sebat et al., 2007). In contrast, members of MPX families more often exhibit ASD traits compared to members 
of SPX families, indicative of a more pronounced role of shared genetic predispositions (Gerdts et al., 2013). 
The association between de novo mutations and ADHD has received little research attention, unlike ASD 
(D'Onofrio et al., 2014). Recent studies that point towards a role for rare genetic variants such as de novo 
mutations in ADHD highlight the need for future studies exploring this issue (Williams et al., 2010, Ben Amor et 
al., 2005, D'Onofrio et al., 2014).  
The present study extends the findings by Rommelse et al. (Rommelse et al., 2008b, Rommelse et al., 
2008c, Rommelse et al., 2008a, Rommelse et al., 2007b, Rommelse et al., 2007c, Rommelse et al., 2007a, 
Rommelse et al., 2008d) by testing whether ADHD-related cognitive deficits are only present in unaffected 
siblings from MPX ADHD families. . If correct, then the use of cognitive endophenotypes in the search for 
ADHD risk genes might be of particular use for MPX, but not SPX ADHD. Further, we aimed to examine 
whether cognitive impairments may be different in SPX and MPX ADHD as indicated by dissimilar cognitive 
profiles in SPX and MPX ADHD patients. So far, no studies have been undertaken that differentiate between 
single- and multi-incidence ADHD, but it is plausible that different heritable forms of ADHD might result in 




Methods and materials 
Participants 
ADHD families were recruited as part of the Dutch part of the International Multicenter ADHD Genetics 
(IMAGE) study (as previously described in Rommelse et al., 2008a). Inclusion criteria for all participants were 
at least two biological siblings (in case families: at least one child with a clinical diagnosis of ADHD) and one 
biological parent willing to participate, offspring age between 4 and 20 years, European Caucasian descent, an 
IQ ≥ 70, and no diagnosis of autism, epilepsy, brain disorders or known genetic disorders, such as Down-
syndrome or Fragile-X-syndrome. All children and parents were carefully phenotyped for ADHD using 
validated and standardized questionnaires and diagnostic interviews. Families were stratified into SPX and MPX 
based on the number of affected individuals. SPX families were required to have a single-affected proband, a 
minimum of one male sibling and all siblings and parents of the proband unaffected by ADHD; MPX families 
were required to have two or more affected individuals. A total of 31 ADHD SPX nuclear families (including 31 
probands and 47 unaffected siblings), 171 ADHD MPX nuclear families (including 264 probands and 123 
unaffected siblings), and 142 control nuclear families (263 children) were included in the current study, see 
Table 1 for sample characteristics and Supplementary Table 1 for a full description of phenotyping and family 
classification (available online). 
 
[Insert Table 1 about here] 
 
Measures 
Cognitive functioning was examined across a range of domains. Full scale IQ was prorated by four subtests of 
the Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale: Similarities, Vocabulary, 
Block Design and Picture Completion (Wechsler, 2002, Wechsler, 2000). The forward condition of Digit Span 
was used to obtain an indication of verbal attention. Four executive function tasks were included: response 
inhibition, visual and verbal working memory, and set shifting. Response inhibition was measured with the 
commonly used Go-NoGo paradigm where participants were instructed to withhold a response when the NoGo 
target was depicted. Visual and verbal working were measured by instructing the participants to correctly 
reproduce sequences of figures (visual) or digits (verbal) that increased in difficulty after each succeeded trial. 
Set shifting was measured by administering a task that required a mixture of compatible and incompatible 
responses, hypothesized to require a higher level of cognitive flexibility. Motor functioning was measured using 
a simple reaction time task and a motor control task. Last, a timing measure was included to measure the 
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variability of motor timing. Table 2 provides an overview of the neurocognitive tasks used. For full task 
descriptions, see Appendix 1 (available online) or elsewhere (Rommelse et al., 2008a). 
 
[Insert Table 2 about here] 
 
Procedure 
Neurocognitive assessment of the children with ADHD and their siblings took place at the VU University 
Amsterdam or at the Radboud university medical center in Nijmegen, the Netherlands and is described in more 
detail elsewhere (Rommelse et al., 2008c). Control children were tested in a quiet room at their school. To avoid 
possible inter-rater or location effects, cognitive performance was measured using standardized computerized 
tasks with fixed settings and computer-calculated outcome measures (e.g. error percentages or mean reaction 
times) across the two sites. In addition, all examiners were thoroughly trained using a standardized training 
protocol and were regularly supervised and observed during task administration to monitor standardized 
assessment across sites and examiners. Stimulants were discontinued for at least 24 hours before testing and non-
stimulants according to their plasma half life to allow for sufficient wash-out. Children were motivated with 
small breaks and received a gift at the end of the session. Additional data collected included blood or saliva 
samples and behavioral data of all family members. The study was approved by the local medical ethics board. 
After the study procedures had been fully explained, parents and children (12 years and older) signed for 
informed consent. Children younger than 12 years of age were asked to give their assent for participation.  
 
Data-analyses 
The percentage of missing data was <5% for all dependent measures, except for stop signal reaction time 
(SSRT). Here, 8.4% of the data were missing. Missings were imputed by means of Expectation Maximization 
(Tabachnick and Fidell, 2001). Analyses were carried out with and without expectation maximization, which 
revealed similar results and led to the same conclusions. Results were therefore reported with missing data 
replaced. To account for the influence of age and sex on neurocognitive performance, we regressed scores for 
each measure on age and sex and used the unstandardized residuals as dependent variables. Most of the 
unstandardized residuals were not normally distributed, therefore, a van der Waerden transformation was applied 
to normalize the dependent measures (Norusis, 1992). This also facilitated the comparison between variables 
since variables were all depicted on the same scale. A number of dependent variables were mirrored so that the 
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z-scores of all measures had the same meaning: lower z-scores indicated poorer performance (e.g. more errors or 
more variable responses).  
  Linear mixed models (LMM) were used to account for the dependency in the data due to inclusion of 
siblings and probands by estimating a random intercept. Dependent variables were the neurocognitive measures 
and group was the independent variable. We contrasted specific groups of interest to answer our research 
questions. LMM analyses were run with group defined as (a) probands versus unaffected siblings versus 
controls, separately for SPX and MPX families, to examine whether cognitive deficits were present in (SPX and 
MPX) probands and MPX, but not SPX, unaffected siblings, (b) SPX versus MPX unaffected siblings to 
examine whether cognitive performance of first-degree relatives was poorer in MPX compared to SPX families, 
and (c) MPX versus SPX probands to examine whether potentially different heritable forms of ADHD would 
result in (dis)similar cognitive profiles in ADHD patients. Furthermore, within family discrepancy scores 
(estimated mean of proband minus mean of unaffected sibling) in SPX versus MPX families were compared to 
examine whether within family contrast was higher in SPX than MPX families. A False Discovery Rate (FDR) 
correction with a q-value setting of 0.05 was applied to control for multiple testing (Benjamini, 2010). Given the 
unequal sample size for MPX and SPX families, emphasis was given to effect sizes next to the p-values. Effect 
sizes (Cohen’s d) were calculated to define small (d = .20), medium (d = .50), and large effects (d = .80) (Cohen, 





Cognitive measures sensitive for SPX-MPX stratification 
Endophenotypes in MPX but not SPX ADHD families 
Testing our first hypothesis, we found indeed that SPX unaffected siblings were unimpaired compared to 
controls on all cognitive domains (all p-values >.17, effect sizes in terms of Cohen’s d ranging from .00-.22) 
except for verbal working memory (p=.029, d=.32), whereas MPX unaffected siblings performed poorer than 
controls on all cognitive domains (p-values <.033, d-values =.21-.49), except for baseline variability (p=.151, 
d=.15). Moreover, comparisons between SPX and MPX unaffected siblings revealed a significantly better 
performance of SPX unaffected siblings in three domains, namely visual working memory (p=.024, d=.40), 
inhibition (p=.005, d=.51), and time estimation (p=.005, d=.49). Within-family discrepancy (proband-unaffected 
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sibling contrast) was larger for SPX probands than for MPX probands for visual working memory (t=2.65, 
p=.012). SPX probands differed significantly from their unaffected siblings on TIQ, visual working memory, and 
variability of time estimation (p-values <.009, d-values =.53-.74), whereas MPX probands differed from their 
unaffected siblings only on TIQ (p<.001, d=.29), see Figure 1 and Table 3. 
 
[Insert Figure 1 about here] 
[Insert Table 3 about here] 
 
Cognitive deficits in MPX versus SPX ADHD probands 
Testing our second hypothesis, we found that the cognitive profiles of SPX and MPX probands were highly 
similar. Both probands from SPX and from MPX families performed significantly worse than controls on 
estimated TIQ, verbal and visual working memory, and variability of time estimation (SPX; p-values <.006, d-
values =.52-.71; MPX: p-values <.001, d-values =.43-.64) and could not be dissociated from each other (p-
values >.20, d-values <.22).  
  Impairments in verbal attention, response inhibition, set shifting, and stability of motor control appeared 
to be most pronounced in MPX ADHD probands. Relative to normal controls, MPX probands showed 
significant impairments (p-values <.029, d-values =.21-.45), whereas SPX probands showed no problems on 
inhibition (p=.341, d=.18), set shifting (p=.218, d=.25), or motor control problems (p=.445, d=.13). The 
significant difference between SPX probands and controls on verbal attention (p=.043, d=.38) did not survive 
FDR correction (q-value =.132). However, SPX and MPX probands could not be dissociated from each other (p-
values >.15, d-values <.28) nor from their unaffected siblings (p-values >.27, d-values <.22) on these domains 
and within-family discrepancy did not differ between SPX and MPX families (t-values <.85, p-values >.30), see 
Figure 2.   
 
[Insert Figure 2] 
 
Measures not sensitive to SPX-MPX stratification 
A few domains were insensitive to SPX-MPX stratification. First, for verbal working memory, a performance 
intermediate between cases and controls was found in MPX and SPX unaffected siblings. Both SPX and MPX 
unaffected siblings performed significantly worse than controls (p=.029, d=.32 and p=.006, d=.27, respectively), 
10 
 
but similar to their affected brothers/sisters (p-values >.13, d-values <.25). However, the difference between 
SPX unaffected siblings and controls became non-significant after FDR correction (q-value =.077). Second, 
probands and unaffected siblings from both SPX and MPX families were equally unimpaired on baseline 
variability (p-values >.10, d-values <.16), see Table 3. 
 
 
Discussion and conclusion 
 
In this study, we aimed to examine whether the cognitive architecture underlying SPX and MPX ADHD families 
is different and useful for parsing the etiological heterogeneity of ADHD. Based on the assumption that 
individuals from SPX families are more likely than individuals from MPX families to develop ADHD as a result 
of sporadic genetic and/or non-genetic causes strictly personal to the patient, we hypothesized that shared 
cognitive deficits between affected and unaffected siblings are present in MPX, but not SPX families. Further, 
we hypothesized that potentially different heritable forms of ADHD might result in dissimilar cognitive profiles 
in SPX and MPX ADHD probands. Consistent with our hypothesis, SPX unaffected siblings were unimpaired 
compared to controls, except for verbal working memory, whereas MPX unaffected siblings showed an 
intermediate performance between cases and controls on most domains. Furthermore, the cognitive profiles of 
SPX and MPX probands were highly similar, except that (a) impairments in verbal attention, response inhibition, 
set shifting and stability of motor control were more pronounced in MPX probands than in SPX probands, and 
(b) when compared to their unaffected siblings, impairments in TIQ, visual working memory and timing abilities 
were more pronounced in SPX cases compared to MPX cases. 
Results largely confirmed the hypothesized dissociation between SPX and MPX families based on 
cognitive performance of probands and their unaffected siblings. Indeed, unaffected siblings from MPX families 
demonstrated a similar (but milder) cognitive vulnerability profile as probands from those families, whereas 
unaffected siblings from SPX families were indistinguishable from controls on all measures but verbal working 
memory. The former finding replicates previous analyses in this sample (Rommelse et al., 2008c, Rommelse et 
al., 2008a, Rommelse et al., 2008b, Rommelse et al., 2007b, Rommelse et al., 2007a, Rommelse et al., 2007c, 
Rommelse et al., 2008d) as well as many previous studies without stratification according to family history. The 
latter finding is novel and indeed suggests that in a percentage of ADHD cases (15.3% in our sample) different 
modes of inheritance may underlie the disorder in the proband that are mostly not shared with the unaffected 
family members. These SPX probands further seem to be relatively more strongly impaired in TIQ, visual 
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working memory and timing abilities. When using unaffected siblings as an ideal reference group (viewed as 
indexing the ‘full potential’ of children with ADHD had they not developed the disorder), an ‘SPX subtype’ of 
ADHD may relate to factors that particularly decrease overall intelligence, visual working memory and time 
estimation. (Rare) genetic variations in genes associated with IQ/intellectual (dis)ability and working memory 
(e.g. COMT) (Green et al., 2013, Boonstra et al., 2008), or environmental factors that have a detrimental effect 
on the development of the brain (e.g. prematurity, low birth weight and fetal distress) (Bilder et al., 2013), might 
thus play particularly important roles in the development of SPX ADHD. This suggests that sporadic ADHD 
might be more prevalent among children with lowered (but still normal) intelligence levels. In contrast, the 
classical response inhibition difficulties as well as verbal attention and motor coordination problems were less 
outspoken in SPX versus MPX ADHD. This may suggest that factors related to these traits (e.g. genetic 
polymorphisms in DAT1 are associated with response inhibition (Boonstra et al., 2008)) are less involved in SPX 
forms of ADHD. The dopamine-modulated basal ganglia neurocircuits are proposed to underpin inhibitory 
control and also play an important role in motor control (Sonuga-Barke, 2005, Fliers et al., 2009). Moreover, 
dopamine plays an important role in attention and auditory processing (Bailey, 2012). Abnormalities in structure 
and function of these circuits caused by genetic variation might thus be hypothesized to be less often observed in 
SPX ADHD. It is challenging to explain why SPX unaffected siblings were impaired in verbal working memory 
and not other cognitive domains. A possible explanation might be that auditory (or verbal) tasks are generally 
more difficult than visual tasks, because auditory measures are more closely related to the attentiveness required 
for daily life than visual measures (Park et al., 2011). Given that (a) SPX unaffected siblings displayed 
somewhat elevated levels of ADHD traits compared to controls (see sample characteristics) and (b) inattention is 
a core characteristic of ADHD, this might explain why SPX unaffected siblings did show some problems in this 
particular area. However, since SPX unaffected siblings were unimpaired on verbal attention, this suggests that 
the verbal working memory deficit is not fully explained by attention problems. Working memory problems in 
SPX unaffected siblings did not extent to the visuo-spatial domain. Possibly, verbal working memory is most 
sensitive to (mild) susceptibility for ADHD. Additional research is however needed to further investigate this 
issue. In any case, these preliminary findings suggest that the rarer SPX forms of ADHD may have partially 
different cognitive underpinnings compared to MPX forms of ADHD and a different pattern of familial-
determined cognitive vulnerabilities, with minimal cognitive vulnerabilities in unaffected siblings.  
In contrast to the situation in SPX families, when selectively analyzing cognitive traits in family 
members from MPX families, virtually for all cognitive domains a strong endophenotypic group pattern was 
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found: unaffected siblings originating from families in which at least two members had ADHD, showed 
substantial cognitive vulnerabilities, similar to their affected sibling. These findings suggest that in families with 
shared risk factors for ADHD, using cognitive traits to detect these underlying causal factors may be a powerful 
approach. Particularly impairments in inhibition, motor control, visual working memory and time estimation 
seem sensitive to such effects and promising areas for further research in this context. These neurocognitive 
functions may be useful in creating more homogeneous subgroups of patients with (MPX) ADHD. This reduces 
heterogeneity and may facilitate our understanding of the involved biological processes, boost power for genetic 
analyses, as well as shed light on the functional outcomes of genes (Gottesman and Gould, 2003).  
The direct comparison between SPX and MPX probands revealed very similar cognitive problems. 
These findings suggest a phenomenon referred to in developmental psychopathology as equifinality (Cicchetti 
and Rogosch, 1996), that is, even though partly different developmental pathways might underlie SPX and MPX 
ADHD, these result in quite similar cognitive deficits and also in similar severity of ADHD symptoms. By 
examining cognitive functions or behavioral symptoms alone, these different underlying etiological factors 
cannot be identified. Instead, causal effects might be muted by the presence of multiple distinct subgroups of 
ADHD patients with different etiologies (Nigg et al., 2005). Although the reality of equifinality is well-
recognized, few solutions have been provided to tease etiological heterogeneity apart. Stratification into SPX and 
MPX seems therefore highly relevant in defining relevant subgroups in order to facilitate research that aims to 
unravel these multiple pathways leading to the same cognitive impairments and ADHD symptomatology 
Our findings further highlight the fact that there is clearly no 1:1 relationship between cognitive 
problems and behavioral problems (de Zeeuw et al., 2008): unaffected siblings from SPX and MPX families did 
not differ from each other regarding (the absence of) ADHD symptoms, yet substantial cognitive vulnerabilities 
were only present in MPX unaffected siblings. This corroborates with the conclusions from a systematic review 
on cognitive (dis)similarities in ADHD persisters and remitters; both were equally impaired at follow-up on 
almost all domains assessed (van Lieshout et al., 2013). It suggests that cognitive vulnerabilities and behavioral 
problems are to some extent disentangled during the course of development. It has been hypothesized that 
neurocognitive deficits in ADHD are epiphenomena instead of core causal factors, that are related to the same 
etiological factors but do not mediate between genes and behavior (Kendler and Neale, 2010, Kebir and Joober, 
2011, Rommelse et al., 2011). This could explain the highly similar cognitive profiles of MPX affected and 
unaffected siblings (who are likely to share etiological risk factors for ADHD), and the highly deviant cognitive 
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profiles of SPX affected and unaffected siblings (where causal risk factors for ADHD appear strictly personal to 
the patient). More longitudinal studies are definitely needed in this fascinating area of research.   
  A number of limitations of this study need to be considered. First, only a small proportion of families 
could be classified SPX. Therefore, we calculated effect sizes to accompany statistical testing. We nonetheless 
restricted interpretation to significant findings; it follows that our study needs replication in larger samples. 
Further, boys were overrepresented in both proband groups and in SPX unaffected siblings, but were 
underrepresented in MPX unaffected siblings and controls. This was due to the fact that a) in childhood, ADHD 
is more frequently diagnosed in males and b) the presence of male unaffected siblings was only required for 
SPX, but not MPX families. However, we do not believe that this has affected the results, since the effect of sex 
was controlled for in this study.  
 In all, our results support the hypothesis that a partly different cognitive architecture may underlie SPX 
and MPX forms of ADHD, which becomes evident when contrasting cognitive performances within families. 
When using performance of unaffected siblings as a reference, TIQ, visual working memory and time estimation 
are particularly impaired in SPX ADHD, suggesting sporadic (non-)genetic causes acting predominantly on 
these domains. Response inhibition and motor control seem relatively unimpaired in SPX forms of ADHD. In 
contrast, familial (MPX) ADHD is related to a wide range of cognitive vulnerabilities, translated to comparable 
(but milder) impairments in unaffected siblings. These findings suggest that different causal pathways may lead 
up to –on the surface- comparable cognitive deficits and ADHD symptoms in children with ADHD, and that 
SPX-MPX stratification may be a step forward in unravelling these various causal pathways. Clinically, 
subgroups of ADHD patients may have distinct prognoses and benefit most from different treatment strategies 
(Nigg et al., 2005), which indicates that awareness of the impact of family history on the presence of ADHD 
traits and cognitive impairments in probands and their unaffected siblings is relevant for the development of 
treatment plans and for genetic counseling.  
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Key bullet points 
 
 The aetiology of ADHD is heterogeneous; small disease-increasing effects of multiple common genetic 
variants likely play a role in multi-incidence (MPX) families, while rare genetic variants (e.g. de novo 
mutations) likely play a role in single-incidence (SPX) families.  
 We may improve our understanding of aetiological heterogeneity of ADHD by studying cognitive 
deficits in SPX versus MPX ADHD.  
 A partly different cognitive architecture appears to underlie SPX and MPX ADHD. MPX ADHD is 
related to a wide range of cognitive vulnerabilities, translated to comparable (but milder) impairments 
in unaffected siblings. SPX ADHD is related to TIQ, visual working memory and time estimation 
impaired in probands but not in siblings. 
 Clinically, SPX and MPX ADHD patients may have distinct prognoses and benefit from different 
treatment strategies. 
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TABLE 1. Sample characteristics 
 
Controls (c)  ADHD probands Unaffected siblings  Group contrasts 
ADHD vs. controls 
 1. SPX 2. MPX 3. SPX 4. MPX  
M  sd  M sd M  sd M  sd M  sd  
Number of kids N = 263  N = 31 N = 264 N = 47 N = 123   
              
Age 11.7 3.2  11.8 2.5 11.5 2.6 10.9 3.4 11.6 3.5  ns 
Sex (% males) 41.1  87.1 73.6 74.5 38.2  1=2=3>4=c 
              
CPRS DSM-IV 
Combined Scale 
46.5 4.5  76.1 8.0 74.8 10.3 48.1 7.3 50.6 9.5  1=2>3=c, 3=4, 4>c 
CTRS DSM-IV 
Combined scale  
46.4 4.5  69.7 8.0 67.7 10.8 48.3 6.3 50.1 7.9  1=2>3=c, 3=4, 4>c 
Note. ADHD = attention-deficit/hyperactivity disorder; SPX = simplex; MPX = multiplex, CPRS = Conners Parent Rating Scale; CTRS = 
Conners teacher rating scale; c = controls; 1 = SPX probands; 2 = MPX probands; 3 = SPX unaffected siblings; 4 = MPX unaffected siblings; 
ns = non significant 
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TABLE 2. Description of the neurocognitive tasks 
Task Measurement potential Dependent variables 






intelligence Total IQ (TIQ) 
Attention   




 Stop Task  inhibition stop signal reaction time (SSRT) 






percentage correct identified targets 
in correct order (part forward) 
 
Shifting Attentional 
Set Visual  
set shifting  





 Baseline Speed baseline variability 
variability of reaction time (SD in 
ms). 
 Tracking 
motor control without 
continuous adaptation 





 Motor Timing timing estimation variability in reaction time (SD) 
Note. For task details, see Appendix 1 or elsewhere (Rommelse et al., 2008a).   




TABLE 3. Means and standard errors of the transformed task variables for SPX and MPX probands, their unaffected siblings and normal controls 




 Group contrasts  Within family 
contrasts  
 
Comparisons between SPX and 
MPX family members 
  
 
 probands  
unaffected 
siblings 
 M (se)  Family type M se M se  p-values*  d-values*  t p  p d  p d 
Endophenotypes in MPX but not SPX ADHD families 
TIQ .29 (.07) 
 SPX -.50 .17 .11 .15  <.001/.264/<.001 .71/.16/.62  
1.421 .164 
 
.212 .22  .496 .05 
 MPX -.26 .07 .06 .09  <.001/.033/<.001 .49/.21/.29   
Visual WM .28 (.06) 
 SPX -.37 .17 .33 .14  <.001/.726/.001 .67/.05/.74  
2.652 .012 
 
.502 .11  .024 .40 




 SPX -.17 .17 .33 .14  .006/.960/.009 .52/.00/.53  
1.909 .065 
 
.516 .12  .005 .49 
 MPX -.29 .06 -.15 .09  <.001/<.001/.168 .64/.49/.14   
Cognitive deficits in MPX but not SPX ADHD probands 
Verbal attention .23 (.06)  
SPX -.14 .17 .04 .14  .043/.239/.378 .38/.20/.19  
.463 .677  .880 .03  .463 .12 
MPX -.17 .06 -.08 .09  <.001/.006/.352 .41/.32/.10  
Inhibition SSRT .24 (.06) 
 SPX .07 .17 .29 .15  .341/.792/.273 .18/.05/.22  
.834 .322 
 
.157 .28  .005 .51 
 MPX -.20 .06 -.22 .09  <.001/<.001/.856 .45/.47/.02   
Set shifting 
 % errors 
.13 (.06) 
 SPX -.11 .18 .06 .15  .218/.690/.444 .25/.07/.17  
.651 .518 
 
.853 .04  .248 .17 




 SPX .07 .18 -.02 .16  .445/.167/.666 .13/.22/.09  
.833 .411 
 
.159 .27  .777 .07 
 MPX -.19 .06 -.09 .09  <.001/.005/.340 .39/.28/.10   
Measures not sensitive to SPX-MPX stratification 
Verbal WM .26 (.07) 
 SPX -.35 .18 -.10 .15  .001/.029/.237 .55/.32/.25  
.673 .654 
 
.363 .16  .606 .07 




 SPX -.01 .18 .-.10 .15  .667/.878/.632 .08/.16/.09  
.400 .691 
 
.764 .06  .340 .02 
 MPX -.07 .06 -.08 .09  .108/.151/.898 .14/.15/.01   
Note. ADHD = attention-deficit/hyperactivity disorder, SPX = simplex, MPX = multiplex, M = mean, se = standard error, WM = working memory. SSRT =  stop signal reaction time. 
Significant group contrasts after FDR correction, are presented in bold.  




FIGURE 1. Cognitive deficits in MPX, but not SPX unaffected siblings from ADHD families. 
 
Note. The interpolation lines represent the mean z-score and the 95% CI of normal controls. The error bars 
represent the 95% confidence interval (CI). Lower z-scores indicate worse performance. Significant group 
differences that survived FDR correction between case groups and controls, are depicted using asterisks (*** p < 
.001, ** p < .01, *p < .05).  SPX and MPX ADHD probands performed significantly worse than controls and 
could not be dissociated from each other on TIQ, visual memory and variability of time estimation. MPX, but 
not SPX unaffected siblings showed similar cognitive impairments on these domains.  
p < .001 p < .001 p = .001 
p = .009 
*** 
 *** 
   * 
 *** 
 *** 
   ** 
    ** 
 *** 
  *** 
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FIGURE 2. Cognitive domains most pronounced in MPX ADHD families 
 
Note. The interpolation lines represent the mean z-score and the 95% CI of normal controls. The error bars 
represent the 95% confidence interval (CI). Lower z-scores indicate worse performance. Significant group 
differences that survived FDR correction between case groups and controls, are depicted using asterisks (*** p < 
.001, ** p < .01, *p < .05).  Probands and unaffected sibling from MPX, but not SPX ADHD families were 
impaired on verbal attention,  inhibition, set shifting and motor control.  
   ***   ** 
    * 
     * 
    *** 
  *** 
   ***   ** 
